Upexi, Inc. (UPXI) Insider Trading Activity

NASDAQ$1.27
Market Cap
$88.07M
Sector
Communication Services
Industry
Internet Content & Information
Rank in Sector
15 of 148
Rank in Industry
4 of 40

UPXI Insider Trading Activity

UPXI Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$4,221,772
13
100
Sells
$0
0
0

Related Transactions

MARSHALL ALLANChief Executive Officer
5
$2.7M
0
$0
$2.7M
Salkind Gene
4
$1.32M
0
$0
$1.32M
Norstrud Andrew JamesChief Financial Officer
1
$100,001
0
$0
$100,001
Dugan Lawrencedirector
3
$97,770
0
$0
$97,770

About Upexi, Inc.

Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.

Insider Activity of Upexi, Inc.

Over the last 12 months, insiders at Upexi, Inc. have bought $4.22M and sold $0 worth of Upexi, Inc. stock.

On average, over the past 5 years, insiders at Upexi, Inc. have bought $1.37M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: MARSHALL ALLAN (Chief Executive Officer) — $2.7M. Salkind Gene () — $1.32M. Norstrud Andrew James (Chief Financial Officer) — $100,001.

The last purchase of 50,000 shares for transaction amount of $90,000 was made by MARSHALL ALLAN (Chief Executive Officer) on 2025‑12‑23.

List of Insider Buy and Sell Transactions, Upexi, Inc.

2025-12-23PurchaseMARSHALL ALLANChief Executive Officer
50,000
0.0748%
$1.80
$90,000
-40.90%
2025-12-16PurchaseMARSHALL ALLANChief Executive Officer
50,000
0.0835%
$2.07
$103,500
-45.85%
2025-12-15PurchaseMARSHALL ALLANChief Executive Officer
100,000
0.1674%
$2.07
$207,000
-45.34%
2025-11-20PurchaseSalkind Genedirector
50,000
0.0861%
$2.55
$127,500
-41.09%
2025-11-17PurchaseSalkind Genedirector
200,000
0.3512%
$2.73
$546,000
-37.69%
2025-07-22PurchaseDugan Lawrencedirector
4,000
0.0103%
$7.50
$30,000
-65.45%
2025-07-16PurchaseDugan Lawrencedirector
11,000
0.0227%
$5.69
$62,600
-62.33%
2025-07-15PurchaseDugan Lawrencedirector
1,000
0.0026%
$5.17
$5,170
-46.54%
2025-07-11PurchaseMARSHALL ALLANChief Executive Officer
161,943
0.1554%
$4.94
$799,998
-48.05%
2025-07-11PurchaseSalkind Gene
20,243
0.0194%
$4.94
$100,000
-48.05%
2025-04-17PurchaseMARSHALL ALLANChief Executive Officer
657,895
56.0777%
$2.28
$1.5M
+89.78%
2025-04-17PurchaseSalkind Gene
241,229
20.5619%
$2.28
$550,002
+89.78%
2025-04-17PurchaseNorstrud Andrew JamesChief Financial Officer
43,860
3.7385%
$2.28
$100,001
+89.78%
2024-03-12PurchaseMARSHALL ALLANCHIEF EXECUTIVE OFFICER
64,150
0.7349%
$0.57
$36,566
-51.35%
2024-03-11PurchaseMARSHALL ALLANCHIEF EXECUTIVE OFFICER
13,623
0.1643%
$0.60
$8,174
-56.38%
2024-03-05PurchaseMARSHALL ALLANCHIEF EXECUTIVE OFFICER
103,013
1.4493%
$0.70
$72,109
-53.97%
2023-12-15PurchaseMARSHALL ALLANCHIEF EXECUTIVE OFFICER
4,535
0.0829%
$0.91
$4,127
-52.10%
2023-12-14PurchaseMARSHALL ALLANCHIEF EXECUTIVE OFFICER
8,381
0.1651%
$0.98
$8,213
-55.16%
2023-12-07PurchaseMARSHALL ALLANCHIEF EXECUTIVE OFFICER
90,001
1.7074%
$0.94
$84,952
-59.56%
2023-12-05PurchaseMARSHALL ALLANCHIEF EXECUTIVE OFFICER
19,296
0.3275%
$0.84
$16,294
-53.00%
Total: 36
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
MARSHALL ALLANChief Executive Officer
4046261
5.835%
$5.14M270
<0.0001%
Salkind Genedirector
218750
0.3155%
$277,812.5050
<0.0001%
Dugan Lawrencedirector
116389
0.1678%
$147,814.0330
Norstrud Andrew JamesChief Financial Officer
59138
0.0853%
$75,105.2610
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$69,542,506
97
-20.55%
$41.45M
$1,582,589
95
18.17%
$39.26M
$897,152,484
62
-9.31%
$557.38M
$5,395,571
48
21.82%
$74.89M
$60,375,399
41
19.10%
$88.54M
$614,673
33
7.64%
$59.21M
$6,652,586
27
-8.73%
$149.72M
$89,319,249
26
-13.24%
$526.55M
$57,529,328
26
19.90%
$300.01M
$199,427,902
23
8.62%
$314.14M
Upexi, Inc.
(UPXI)
$1,010,220
15
-47.63%
$88.07M
$2,761,053
15
-31.44%
$425.42M
$3,614,955
10
22.04%
$1.04B
$8,002,182
6
15.05%
$632.38M
$59,522,323
5
5.85%
$636.47M
$1,003,217
4
-29.71%
$26.82M
$4,118
3
-37.43%
$3.91M
$662,439
3
43.65%
$1.66B
$591,920
1
-23.03%
$53.81M

UPXI Institutional Investors: Active Positions

Increased Positions47+54.65%11M+73.15%
Decreased Positions40-46.51%9M-57.88%
New Positions25New6MNew
Sold Out Positions28Sold Out8MSold Out
Total Postitions93+8.14%18M+15.27%

UPXI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Polar Asset Management Partners Inc.$9,550.007.94%5M+5MNew2025-09-30
Alyeska Investment Group, L.P.$2,388.001.98%1.25M+1MNew2025-09-30
Mmcap International Inc. Spc$1,465.001.22%766,933+766,933New2025-09-30
Ubs Group Ag$1,446.001.2%757,244+720,990+1,988.72%2025-09-30
Susquehanna International Group, Llp$1,435.001.19%751,479+637,356+558.48%2025-09-30
Vanguard Group Inc$1,358.001.13%710,744+209,907+41.91%2025-09-30
Blackrock, Inc.$1,303.001.08%682,037+682,037New2025-09-30
Marex Group Plc$1,230.001.02%644,176+644,176New2025-09-30
Shariaportfolio, Inc.$1,189.000.99%622,728+622,728New2025-09-30
Jane Street Group, Llc$1,174.000.98%614,870+614,870New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.